Gedatolisib
CAS 1197160-78-3Small Molecule
Overview
Gedatolisib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL592445).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Gedatolisib expires — and exclusivity 14 Jul 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
- Canonical SMILES
- CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6
- InChIKey
- DWZAEMINVBZMHQ-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Gedatolisib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.